前列腺癌的血清疗法革命：基础知识、临床应用、未决问题和未来展望

IF 9.6 1区医学 Q1 ONCOLOGY

Cancer treatment reviews Pub Date : 2024-02-11 DOI:10.1016/j.ctrv.2024.102698

Matteo Bauckneht , Chiara Ciccarese , Riccardo Laudicella , Claudia Mosillo , Francesca D'Amico , Annunziato Anghelone , Alessandro Strusi , Viria Beccia , Sergio Bracarda , Giuseppe Fornarini , Giampaolo Tortora , Roberto Iacovelli

{"title":"前列腺癌的血清疗法革命：基础知识、临床应用、未决问题和未来展望","authors":"Matteo Bauckneht , Chiara Ciccarese , Riccardo Laudicella , Claudia Mosillo , Francesca D'Amico , Annunziato Anghelone , Alessandro Strusi , Viria Beccia , Sergio Bracarda , Giuseppe Fornarini , Giampaolo Tortora , Roberto Iacovelli","doi":"10.1016/j.ctrv.2024.102698","DOIUrl":null,"url":null,"abstract":"<div><p>In the last years, theranostics has expanded the therapeutic options available for prostate cancer patients. In this review, we explore this dynamic field and its potential to revolutionize precision medicine for prostate cancer. We delve into the foundational principles, clinical applications, and emerging opportunities, emphasizing the potential synergy between radioligand therapy and other systemic treatments. Additionally, we address the ongoing challenges, including optimizing patient selection, assessing treatment responses, and determining the role of theranostics within the broader landscape of prostate cancer treatment.</p></div>","PeriodicalId":9537,"journal":{"name":"Cancer treatment reviews","volume":null,"pages":null},"PeriodicalIF":9.6000,"publicationDate":"2024-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0305737224000161/pdfft?md5=3dfb0b74c0926897345eea7f47243cf5&pid=1-s2.0-S0305737224000161-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives\",\"authors\":\"Matteo Bauckneht , Chiara Ciccarese , Riccardo Laudicella , Claudia Mosillo , Francesca D'Amico , Annunziato Anghelone , Alessandro Strusi , Viria Beccia , Sergio Bracarda , Giuseppe Fornarini , Giampaolo Tortora , Roberto Iacovelli\",\"doi\":\"10.1016/j.ctrv.2024.102698\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>In the last years, theranostics has expanded the therapeutic options available for prostate cancer patients. In this review, we explore this dynamic field and its potential to revolutionize precision medicine for prostate cancer. We delve into the foundational principles, clinical applications, and emerging opportunities, emphasizing the potential synergy between radioligand therapy and other systemic treatments. Additionally, we address the ongoing challenges, including optimizing patient selection, assessing treatment responses, and determining the role of theranostics within the broader landscape of prostate cancer treatment.</p></div>\",\"PeriodicalId\":9537,\"journal\":{\"name\":\"Cancer treatment reviews\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":9.6000,\"publicationDate\":\"2024-02-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0305737224000161/pdfft?md5=3dfb0b74c0926897345eea7f47243cf5&pid=1-s2.0-S0305737224000161-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer treatment reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0305737224000161\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0305737224000161","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

在过去几年中，前列腺癌治疗技术为前列腺癌患者提供了更多的治疗选择。在这篇综述中，我们将探讨这一充满活力的领域及其彻底改变前列腺癌精准医疗的潜力。我们深入探讨了基础原理、临床应用和新兴机遇，强调了放射性配体疗法与其他系统治疗之间的潜在协同作用。此外，我们还探讨了当前面临的挑战，包括优化患者选择、评估治疗反应以及确定治疗仪在前列腺癌治疗大环境中的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives

In the last years, theranostics has expanded the therapeutic options available for prostate cancer patients. In this review, we explore this dynamic field and its potential to revolutionize precision medicine for prostate cancer. We delve into the foundational principles, clinical applications, and emerging opportunities, emphasizing the potential synergy between radioligand therapy and other systemic treatments. Additionally, we address the ongoing challenges, including optimizing patient selection, assessing treatment responses, and determining the role of theranostics within the broader landscape of prostate cancer treatment.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer treatment reviews 医学-肿瘤学

CiteScore

21.40

自引率

0.80%

发文量

109

审稿时长

13 days

期刊介绍： Cancer Treatment Reviews Journal Overview: International journal focused on developments in cancer treatment research Publishes state-of-the-art, authoritative reviews to keep clinicians and researchers informed Regular Sections in Each Issue: Comments on Controversy Tumor Reviews Anti-tumor Treatments New Drugs Complications of Treatment General and Supportive Care Laboratory/Clinic Interface Submission and Editorial System: Online submission and editorial system for Cancer Treatment Reviews